menu search

Rosen, leading trial attorneys, encourages adapthealth corp. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ahco

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, an...

November 3, 2023, 8:54 pm

Open society foundations announce 2023 soros justice fellows

New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to announce the 20...

November 3, 2023, 8:52 pm

Clearstar announces appointment of mike pritts as chief executive officer

New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in the software and technology sectors. Alpharett...

November 3, 2023, 8:50 pm

Global market weekly recap: oct. 30 – nov. 3, 2023

Equities and crypto were big winners this week as traders navigated between fresh business sentiment surveys, geopolitics and central bank statements....

November 3, 2023, 8:34 pm

Collective audience begins trading under new nasdaq ticker symbol, caud

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq:CAUD), a leading provide...

November 3, 2023, 8:30 pm

Univest securities, llc announces closing of $10 million registered direct offering for its client gd culture group limited (nasdaq: gdc)

New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA...

November 3, 2023, 8:30 pm

Cornerstone funds announce continuing monthly distributions and reset distribution amounts for 2024

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...

November 3, 2023, 8:30 pm

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 20...

November 3, 2023, 8:30 pm

Constellation brands announces expiration of canopy growth warrants

VICTOR, N.Y., Nov. 03, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beve...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...

November 3, 2023, 8:30 pm

Alliant energy corporation (lnt) q3 2023 earnings call transcript

Alliant Energy Corporation (NASDAQ:LNT ) Q3 2023 Earnings Conference Call November 3, 20...

November 3, 2023, 8:15 pm

The real good food company to report third quarter 2023 financial results on friday, november 10 at 10:00 a.m. eastern time

CHERRY HILL, N.J., Nov. 03, 2023 (GLOBE NEWSWIRE) — The Real Good Food Company Inc. (Nasdaq: RGF) (�...

November 3, 2023, 8:05 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-...

November 3, 2023, 8:05 pm

Gd culture group limited announces closing of $10 million registered direct offering priced at-the-market under nasdaq rules

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — GD Culture Group Limited (“GDC” or the “Company”) ...

November 3, 2023, 8:05 pm

November 2023 letter to shareholders

VANCOUVER, Washington, Nov. 03, 2023 (GLOBE NEWSWIRE) — Dear Shareholders, We write to provide an upd...

November 3, 2023, 8:02 pm

Prime medicine reports third quarter 2023 financial results and provides business updates

— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...

November 3, 2023, 8:01 pm

Astec to present at baird’s 2023 global industrial conference

CHATTANOOGA, Tenn., Nov. 03, 2023 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced ...

November 3, 2023, 8:01 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial...

November 3, 2023, 8:01 pm


Search within

Pages Search Results: